Moore Capital Management’s PTC Therapeutics PTCT Stock Holding History

Moore Capital Management’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Hold	0	–	–	–	469
2023 Q3	–	Sell	-25,000	Closed	-$1.02M	–	507
2023 Q2	$1.02M	Sell	25,000 -3,500	-12%	-$142K	0.02%	275
2023 Q1	$1.38M	Sell	28,500 -1,500	-5%	-$72.7K	0.03%	246
2022 Q4	$1.15M	Buy	30,000 +10,000	+50%	+$382K	0.03%	302
2022 Q3	$1M	Sell	20,000 -20,000	-50%	-$1M	0.02%	390
2022 Q2	$1.6M	Hold	40,000	–	–	0.04%	342
2022 Q1	$1.49M	Hold	40,000	–	–	0.04%	381
2021 Q4	$1.59M	Hold	40,000	–	–	0.03%	409
2021 Q3	$1.49M	Hold	40,000	–	–	0.02%	457
2021 Q2	$1.69M	Hold	40,000	–	–	0.02%	462
2021 Q1	$1.89M	Sell	40,000 -1,572	-4%	-$74.4K	0.02%	445
2020 Q4	$2.54M	Sell	41,572 -8,428	-17%	-$514K	0.03%	310
2020 Q3	$2.34M	Buy	50,000 +10,000	+25%	+$468K	0.04%	228
2020 Q2	$2.03M	Hold	40,000	–	–	0.05%	176
2020 Q1	$1.78M	Sell	40,000 -170,611	-81%	-$7.61M	0.07%	111
2019 Q4	$10.1M	Sell	210,611 -27,844	-12%	-$1.34M	0.33%	80
2019 Q3	$8.07M	Buy	238,455 +48,337	+25%	+$1.63M	0.32%	82
2019 Q2	$8.56M	Buy	190,118 +90,118	+90%	+$4.06M	0.2%	97
2019 Q1	$3.76M	Buy	100,000 +10,000	+11%	+$376K	0.12%	161
2018 Q4	$3.09M	Sell	90,000 -10,000	-10%	-$343K	0.12%	111
2018 Q3	$4.7M	Hold	100,000	–	–	0.1%	121
2018 Q2	$3.37M	Sell	100,000 -75,000	-43%	-$2.53M	0.08%	136
2018 Q1	$4.74M	Buy	175,000 +125,000	+250%	+$3.38M	0.09%	130
2017 Q4	$834K	Hold	50,000	–	–	0.02%	193
2017 Q3	$1M	Sell	50,000 -50,000	-50%	-$1M	0.02%	171
2017 Q2	$1.83M	Hold	100,000	–	–	0.06%	124
2017 Q1	$984K	Buy	100,000 +50,000	+100%	+$492K	0.03%	145
2016 Q4	$546K	Sell	50,000 -50,000	-50%	-$546K	0.02%	133
2016 Q3	$1.4M	Buy	+100,000	New	+$1.4M	0.05%	121
2015 Q3	–	Sell	-43,000	Closed	-$2.07M	–	341
2015 Q2	$2.07M	Buy	43,000 +23,000	+115%	+$1.11M	0.04%	255
2015 Q1	$1.22M	Buy	+20,000	New	+$1.22M	0.03%	275